Citation Impact
Citing Papers
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis
1998
A Risk-Benefit Assessment of Tramadol in the Management of Pain
1996
Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system
2011
Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.
1995
Protein nanoparticles as drug carriers in clinical medicine
2008
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Allergen-induced late-phase airways obstruction in the pig: mediator release and eosinophil recruitment
1995
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
2005
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Pharmaceutical and Physical Properties of Paclitaxel (Taxol †) Complexes with Cyclodextrins ‡
1995
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Cremophor EL
2001 Standout
Paclitaxel (Taxol)
1995 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Adverse Drug Events Related to Dosage Forms and Delivery Systems
1996
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patients
2000
Cardiotoxicity of Chemotherapeutic Agents
2000
Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions
1997
Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study
1998
Male–female differences in fertility and blood pressure in ACE-deficient mice
1995 StandoutNatureNobel
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Hypersensitivity reactions from taxol.
1990 Standout
Clinical Pharmacology of Tramadol
2004 Standout
Multiple Sclerosis
2000 Standout
Role of Formulation Vehicles in Taxane Pharmacology
2001
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes
1994
Cardiac disturbances during the administration of taxol.
1991
Paclitaxel and its formulations
2002 Standout
Tramadol
1993
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Cancer of the Ovary
2004 Standout
Albumin-bound paclitaxel: a next-generation taxane
2006
Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model.
1993
Cyclocytidine-induced release of nerve growth factor from mouse submandibular glands enhances regeneration of sympathetic fibers in adult mice
1985 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Pancreatic trypsin inhibitor
1983 StandoutNobel
LOCATION OF RENIN (OR A RENIN‐LIKE SUBSTANCE) IN THE SUBMAXILLARY GLANDS OF ALBINO MICE
1965
Pharmaceutical Development of (Investigational) Anticancer Agents for Parenteral Use-A Review
1996
Agents that Release Histamine from Mast Cells
1983
Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra
1982 StandoutNobel
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor.
1986 StandoutNobel
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Separation of isorenin activity from nerve growth factor (NGF) activity in mouse submaxillary gland extracts
1973
Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175.
1996
INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES
1977 Standout
Isolation from a Salivary Gland of Granules Containing Renin and Kallikrein
1968
Lectins: Cell-Agglutinating and Sugar-Specific Proteins
1972 StandoutScience
Biochemie natürlicher Proteinase‐Inhibitoren
1974
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Simultaneous isolation of trypsin inhibitor and anti-A phytohemagglutinin from Vicia cracca by means of biospecific adsorption
1970
An affinity column for renin
1973 StandoutNobel
Cyclodextrin Drug Carrier Systems
1998 Standout
Isolation and characterization of renin-like enzymes from mouse submaxillary glands
1972 StandoutNobel
Nanoparticles in Photodynamic Therapy
2015 Standout
Biochemistry of Natural Proteinase Inhibitors
1974
Studies on Renin with Synthetic Substrates
1969
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Pharmacological Effects of Formulation Vehicles
2003
Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra
1982 StandoutNobel
Somatic and behavioural postnatal effects of fetal injections of nerve growth factor antibodies in the rat
1981 StandoutNatureNobel
Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream.
1986 StandoutNobel
Human epidermal growth factor: isolation and chemical and biological properties.
1975 StandoutNobel
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Genetic and endocrine control of renin activity in the submaxillary gland of the mouse
1981
Histamine release as cause of acute hypotension following rapid colloid infusion
1970
Refined 2.5 Å X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor
1983
Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer
2005
Studies on the partial isolation of human renin
1970
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Structure, expression, and regulation of the murine renin genes.
1991
Phase I trial of cremophor EL with bolus doxorubicin.
1998
A non- surfactant formulation for alfaxalone based on an amorphous cyclodextrin: Activity studies in rats and dogs
1990
Assignment of the 1H nuclear magnetic resonance spectrum of the trypsin inhibitor E from Dendroaspis polylepis polylepis
1982 StandoutNobel
High field 13C NMR studies at 90.5 MHz of the methyl groups in the basic pancreatic trypsin inhibitor
1977 StandoutNobel
Characterization of the proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance
1983 StandoutNobel
Assignment of the 1H nuclear magnetic resonance spectrum of the trypsin inhibitor homologue K from Dendroaspis polylepis polylepis
1983 StandoutNobel
Postnatal developmental changes in submandibular glands of rats and mice.
1980
The patch-clamp technique in the study of secretion
1989 StandoutNobel
Works of A. Schmal being referenced
Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: Analysis of various components in cremophor El and development of a compound with reduced toxicity
1982
HISTAMINE RELEASE IN HUMAN SUBJECTS BY MODIFIED GELATIN (HAEMACCEL) AND DEXTRAN: AN EXPLANATION FOR ANAPHYLACTOID REACTIONS OBSERVED UNDER CLINICAL CONDITIONS?
1976
Reliability and practicability of the fluorometric-fluoroenzymatic histamine determination in pathogenetic studies on peptic ulcer: Detection limits and problems with specificity
1987
A critical view concerning metabolism and physiological function of histamine in the gastric mucosa.
1977
�ber das renin�hnliche Enzym der Glandula submaxillaris der wei�en Maus
1962
Anreicherung und Immunspezifität des Isorenins der Glandula submaxillaris der Maus
1968
Zur Identität des Progressiv-Antikallikreins mit α-Antitrypsin aus Humanserum
1969
Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent
1977
Histamine in the pig: Determination, distribution, release and pharmacological actions
1971
Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol
1987
Verwendung wasserunlöslicher Derivate des Trypsin-Kallikrein -Inhibitors zur Isolierung von Kallikreinen und von Plasmin
1969
Über ein Iso-Enzym des Renins und über die Isolierung eines biologisch aktiven Spaltproduktes seines Substrates
1963
Die hormonelle Beeinflussung des Isorenin-Spiegels der Submandibularisdrüse der weißen Maus und zur Lokalisierung des Enzyms in der Drüse
1966
Zum Mechanismus der Sekretionsstimulierung und Blutdrucksenkung durch Histalog (Betazol�): Histaminliberierung und Potenzierung der Wirkung von Kininen und Serotonin
1970